Institute for Wealth Management’s Eton Pharmaceutcials ETON Stock Holding History

Institute for Wealth Management’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63K	Buy	+73	New	+$2.14K	﹤0.01%	1551

Other funds holding ETON

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Institute for Wealth Management's ETON Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 73 shares worth $2.63K. The stake represents ﹤0.01% of the portfolio and ranks #1551 among its holdings.

59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Institute for Wealth Management held 73 shares of Eton Pharmaceutcials worth $2.63K as of Q2 2026.
Eton Pharmaceutcials was a new Institute for Wealth Management position in Q2 2026.
Eton Pharmaceutcials made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1551 holding.
59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.